LifeStance Health Group
LFST on Nasdaq. LifeStance Health Group provides mental health care to patients through clinics and virtual visits paid by insurance. Market value $4.7bn.
Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.
Should I look at this?
Look carefully before going further
Why it could be worth it
Read the warning sign in its own filings
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $3.76 of spare cash in the past 12 months. A savings account pays about $4.
You pay 59.7 years of operating profit for the business. The average large US company costs around 18.
Each dollar kept in the business earns -9 cents a year. Above 10 is good.
Quality score: 48 of 100. Price score: 26 of 100. Our list needs 70 on quality and 60 on price.
$12.12 a share, 154% above its 1-year low
Over the past year the price has ranged from $4.77 to $13.56.
Pays no dividend
Prices from Tuesday’s close (6 October).
Five years of cash, in billions
Spare cash swings from quarter to quarter here: $174 million in the past 12 months, $110 million in the year to December 2025.
| Revenue | |||||
| Revenue | $668m | $860m | $1.1bn | $1.3bn | $1.4bn |
| Operating margin | |||||
| Operating margin | -42.9% | -24.5% | -17.9% | -2.5% | 1.7% |
| Debt to equity | |||||
| Debt to equity | 0.10 | 0.15 | 0.20 | 0.20 | 0.19 |
| Shares outstanding | |||||
| Shares outstanding | 0.38bn | 0.38bn | 0.38bn | 0.39bn | 0.38bn |
Health checks
- Free cash flow positive2 of 5 years
- Accounting looks honest (Beneish)Not enough data
- Financial strength (Piotroski)7 of 8 checks we could run
- Profit backed by cash (accruals)Yes
- Debt0.19× equity
- Revenue growth, five yearsStrong, 20.9% a year
- Buying back its own sharesRoughly flat
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $435 million last quarter, up 26% on a year ago.
- Profit: $24 million, after a loss of $4 million a year ago.
- It keeps 5 cents of each $1 of sales as operating profit, up from 0 cents a year earlier.
- Spare cash over the past 12 months: $174 million, up from $120 million.
- About the same number of shares as a year ago.
- Debt is $50 million more than cash, down from $97 million a year ago.
- Sales grew on a year ago in each of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| September 2024 | $313m |
| December 2024 | $325m |
| March 2025 | $333m |
| June 2025 | $345m |
| September 2025 | $364m |
| December 2025 | $382m |
| March 2026 | $403m |
| June 2026 | $435m |
| Quarter to | Amount |
|---|---|
| September 2024 | $709,000 |
| December 2024 | -$7m |
| March 2025 | $709,000 |
| June 2025 | -$4m |
| September 2025 | $1m |
| December 2025 | $12m |
| March 2026 | $14m |
| June 2026 | $24m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 25 February 2026
- Next quarterly (estimated, 10-Q)
- 5 November 2026
Who owns it
2 long-term investors we follow own it, unchanged from 2 last quarter. 287 funds in all.
| Fund | Value | Share of that fund | Change |
|---|---|---|---|
| First Eagle Investment ManagementMatthew McLennan | $33m | <0.1% | Added |
| Gotham Asset ManagementJoel Greenblatt | $2m | <0.1% | Added |
Largest holders overall
- TPG GP A$1.2bnCut
- FMR$624m
- BlackRock$389mAdded
- Summit Partners L P$250mCut
- Vanguard Portfolio Management$150mAdded
- Jennison Associates$129mAdded
- Dimensional Fund Advisors LP$122mAdded
- Vanguard Capital Management$104mAdded
- State Street$88mAdded
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS$64mCut
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
4 investors own more than 5%.
- TPG GP A, LLCPassive investorat least 25.7%−3.6 pts(filed with 2 related holders)Since 30 June 2026
- FMR LLCPassive investorat least 15.0%+3.0 pts(filed with 1 related holder)Since 31 March 2026
- BlackRock, Inc.Passive investor10.1%+1.8 ptsSince 30 September 2026
- Summit Partners, L.P.Passive investorat least 6.1%−1.4 pts(filed with 5 related holders)Since 30 June 2026
| Holder | Stake | Since | |
|---|---|---|---|
TPG GP A, LLC Passive investor | at least 25.7%−3.6 pts (filed with 2 related holders) | 30 June 2026 | |
FMR LLC Passive investor | at least 15.0%+3.0 pts (filed with 1 related holder) | 31 March 2026 | |
BlackRock, Inc. Passive investor | 10.1%+1.8 pts | 30 September 2026 | |
Summit Partners, L.P. Passive investor | at least 6.1%−1.4 pts (filed with 5 related holders) | 30 June 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought shares on the open market in the last 12 months. 8 sold $104m, $13m of it under preset trading plans.
- Paunovich VukasinChief Technology OfficerSold
- Date
- 2 September 2026
- Shares
- 42,067
- Price
- $12.87
- Value
- $541,402
- DeLuca TeresaDirectorSold
- Date
- 14 August 2026
- Shares
- 7,500
- Price
- $12.68
- Value
- $95,100
- DeLuca TeresaDirectorSold
- Date
- 13 August 2026
- Shares
- 20,441
- Price
- $12.23
- Value
- $249,993
- Burdick Kenneth ADirectorSold
- Date
- 11 August 2026
- Shares
- 500,000
- Price
- $11.51
- Value
- $6m
- Paunovich VukasinChief Technology OfficerSoldunder a preset trading plan
- Date
- 10 August 2026
- Shares
- 44,394
- Price
- $10.85
- Value
- $481,675
- Miller Lisa KChief Operating OfficerSoldunder a preset trading plan
- Date
- 10 August 2026
- Shares
- 47,912
- Price
- $10.85
- Value
- $519,845
- Bessler RobertDirectorSoldunder a preset trading plan
- Date
- 26 June 2026
- Shares
- 894,337
- Price
- $10.13
- Value
- $9m
- Bessler RobertDirectorSold
- Date
- 12 May 2026
- Shares
- 575,034
- Price
- $8.02
- Value
- $5m
- Shuey EricDirectorSold
- Date
- 12 May 2026
- Shares
- 243,362
- Price
- $8.02
- Value
- $2m
- BLACK DARREN M.DirectorSold
- Date
- 12 May 2026
- Shares
- 5,899,661
- Price
- $8.02
- Value
- $47m
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 2 September 2026 | Paunovich Vukasin Chief Technology Officer | Sold | 42,067 | $12.87 | $541,402 |
| 14 August 2026 | DeLuca Teresa Director | Sold | 7,500 | $12.68 | $95,100 |
| 13 August 2026 | DeLuca Teresa Director | Sold | 20,441 | $12.23 | $249,993 |
| 11 August 2026 | Burdick Kenneth A Director | Sold | 500,000 | $11.51 | $6m |
| 10 August 2026 | Paunovich Vukasin Chief Technology Officer | Sold under a preset trading plan | 44,394 | $10.85 | $481,675 |
| 10 August 2026 | Miller Lisa K Chief Operating Officer | Sold under a preset trading plan | 47,912 | $10.85 | $519,845 |
| 26 June 2026 | Bessler Robert Director | Sold under a preset trading plan | 894,337 | $10.13 | $9m |
| 12 May 2026 | Bessler Robert Director | Sold | 575,034 | $8.02 | $5m |
| 12 May 2026 | Shuey Eric Director | Sold | 243,362 | $8.02 | $2m |
| 12 May 2026 | BLACK DARREN M. Director | Sold | 5,899,661 | $8.02 | $47m |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
1 serious warning sign in LifeStance Health Group’s filings.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 25 Feb 2026, plus the 10-Q filed 6 Aug 2026 and 8 later 8-Ks.
Weak checks on its own accounts
SeriousThe company said its checks on its own accounts did not work at the end of its latest quarter. Mistakes could slip into the numbers.
“Based upon that evaluation, as a result of the material weaknesses in internal control over financial reporting described below, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of June 30, 2026 due to the material weaknesses described below.”
Show the full paragraph
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based upon that evaluation, as a result of the material weaknesses in internal control over financial reporting described below, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of June 30, 2026 due to the material weaknesses described below.
From the 10-Q filed 6 August 2026, Part I, Item 4. Controls and Procedures. Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
- It isn't cheap on profits: 59.7× operating profit.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.